Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis
Status:
Suspended
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
This pilot study evaluates the safety and feasibility of losartan in pediatric patients with
pulmonary vein stenosis.
It is an open label single arm interventional study. The patient population involves
pediatric patients with stenosis in 2 or more pulmonary veins. Patients will be given
losartan for 1 year. Outcomes include measures of safety/adverse events and progression of
pulmonary vein stenosis.